jeff smith pfizer news - Search News

Pfizer, Starboard Value

CNBC on MSN · 3d

Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments

Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential for growth in Kenvue, and more.

BioSpace · 11h

Analysts Rally Around Pfizer CEO Amid Starboard Challenge

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the company’s leadership. However, analysts are supportive of the embattled executive.

Wall Street Journal · 3d

Starboard Chief Criticizes Pfizer’s R&D Investments

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and through mergers and acquisitions.

Business Insider India on MSN · 18d

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary.

Reuters on MSN · 3d

Starboard Value CEO says Pfizer's board should hold management accountable

Activist hedge fund Starboard Value's chief investment officer Jeffrey Smith said on Tuesday that drugmaker Pfizer Inc's board needs to hold management accountable for its underperformance. "We measure success in producing blockbuster drugs and we all get measured by our track records.

2d

What activist hedge fund Starboard wants from Pfizer

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

3don MSN

An Activist Makes the Case Against Pfizer. CEO Bourla is in His Sights

Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.

Starboard spells out its concerns with Pfizer's direction

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

3d

Activist Investor Takes Aim at Pfizer: $20 Billion in Value Lost

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app ...

3d

Starboard calls for Pfizer board to ‘hold management accountable’

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...

Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results